Bowel Research UK launches today (29 September) following the merger of Bowel Disease Research Foundation and Bowel & Cancer Research.
The two have merged to focus resources and expertise. Between them, the two charities have more than 50 years’ experience and have invested more than £9 million in research over the last ten years.
As Bowel Research UK, the charity has committed to a £1million funding target for early-stage research into bowel conditions over the next 12-18 months.
Most recently, Bowel Research UK has been involved in CovidSurg, an international collaboration covering 88 countries, 1032 centres, and more than 52,300 patients to understand the outcomes of Covid-19 infected patients who undergo surgery.
Professor Charles Knowles, Chair of the Grants Committee at Bowel Research UK, commented:
“Bowel Research UK has committed to a target of £1m for new research and we encourage early career researchers specialising in bowel disease to apply for this funding. We believe that, by investing in our scientific and medical communities today, a cure for bowel cancer and effective treatments to mitigate, or entirely eradicate, other bowel diseases are entirely possible in the future.”
Bowel Research UK CEO, Rebecca Porta, added:
“More than 42,000 people are diagnosed with bowel cancer each year in the UK, and an increasing number are impacted by life-changing bowel conditions, making the work of Bowel Research UK more critical than ever. Our patient-driven research will help deliver much-needed improvements in diagnosis, treatment and care.”
218 total views, 2 views today
219 total views, 3 views today